2,3-dinor-thromboxane b2 has been researched along with 6-ketoprostaglandin f1 alpha in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (47.50) | 18.7374 |
1990's | 32 (40.00) | 18.2507 |
2000's | 10 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benthin, G; Granström, EF; Persson, L; Rångemark, C; Wennmalm, A; Winell, S | 1 |
Busch, C; Leonhardt, A; Schweer, H; Seyberth, HW | 1 |
Bernard, GR; Christman, BW; Groves, BM; King, GA; Loyd, JE; McPherson, CD; Newman, JH | 1 |
Rångemark, C; Wennmalm, A | 1 |
Tulppala, M; Viinikka, L; Ylikorkala, O | 1 |
Kurki, T; Viinikka, L; Ylikorkala, O | 1 |
Falardeau, P; Grose, JH; Hui, R; Lebel, M; Robillard, M | 1 |
Aitokallio-Tallberg, AM; Jung, JK; Kim, SJ; Viinikka, LU; Ylikorkala, RO | 1 |
Cashman, SJ; Dollery, CT; Fuller, RW; Rees, AJ; Ritter, JM; Ward, PS | 1 |
Edhag, O; Gréen, K; Henriksson, P; Rasmanis, G; Vesterqvist, O | 2 |
Benthin, G; Granström, EF; Persson, L; Petersson, AS; Wennmalm, A; Winell, S | 1 |
Beetens, J; De Clerck, F; Höller, M; Tegtmeier, F; Weber, C | 1 |
Hirvonen, E; Saure, A; Viinikka, L; Ylikorkala, O | 1 |
Benthin, G; Caidahl, K; Granström, EF; Lanne, B; Persson, L; Petersson, AS; Wennmalm, A; Winell, S | 1 |
Catella, F; Fitzgerald, GA; Lupinetti, MD; Sheller, JR | 1 |
Gréen, K; Vesterqvist, O | 3 |
Barrow, SE; Beacham, J; Cockcroft, JR; Doktor, HS; Ritter, JM | 1 |
Benigni, A; Campoleoni, A; Chiabrando, C; Fanelli, R; Piccinelli, A; Pinciroli, V | 1 |
Brunkhorst, R; Förstermann, U; Frei, U; Frölich, JC; Gréen, K; Haas, J; Koch, KM; Kühn, K; Vesterqvist, O | 1 |
Drvota, V; Grèen, K; Vesterqvist, O | 1 |
Dechavanne, M; Guichardant, M; Lagarde, M; Rousson, D; Viala, JJ | 1 |
Cotton, RB; Kühl, PG; Schweer, H; Seyberth, HW | 1 |
Aitokallio-Tallberg, A; Viinikka, L; Ylikorkala, O | 1 |
Edlund, A; Henriksson, P; Wennmalm, A | 1 |
Doran, JB; FitzGerald, GA; Reilly, IA; Smith, B | 1 |
Edlund, A; FitzGerald, GA; Sevastik, B; Wennmalm, A | 2 |
Boss, AH; Catella, F; Ciabattoni, G; Daffonchio, L; Daugherty, J; Dray, F; FitzGerald, GA; Patrono, C | 1 |
Bellucci, S; Castagnoli, MN; Maclouf, J; Pradelles, P | 1 |
Alessandrini, P; FitzGerald, GA; Knapp, HR; Reilly, IA | 1 |
Fitzgerald, GA; Reilly, IA; Roy, L | 1 |
Courpron, P; Croset, M; Dechavanne, M; Lagarde, M; Sedivy, P; Vericel, E | 1 |
Haapanen, A; Koskenvuo, M; Lassila, R; Laustiola, KE; Schweer, H; Seyberth, HW | 1 |
Kühl, PG; Rascher, W; Schweer, H; Seyberth, HW; Soeding, K; Tulassay, T | 1 |
Fitzgerald, DJ; FitzGerald, GA; Fragetta, J | 1 |
Maeda, K; Niwa, T; Shibata, M; Yamada, K | 1 |
Gréen, K; Grill, V; Vesterqvist, O | 1 |
Alessandrini, P; Feman, S; FitzGerald, GA; McRae, J | 1 |
Gréen, K; Lewin, J; Swedenborg, J; Vesterqvist, O | 1 |
Feuerstein, TJ; Förstermann, U | 1 |
Axelsson, K; Berséus, O; Gréen, K; Schött, U; Vesterqvist, O | 1 |
Vesterqvist, O | 1 |
Cotton, RB; FitzGerald, GA; Kuehl, PG | 1 |
Edhag, O; Green, K; Henriksson, P; Vesterqvist, O; Wennmalm, A | 1 |
Catella, F; Fitzgerald, DJ; FitzGerald, GA; Roy, L | 1 |
Boss, AH; Catella, F; Cibattoni, G; Filabozzi, P; Patrignani, P; Patrono, C; Pierucci, A; Pugliese, F; Simonetti, BM | 1 |
Gréen, K; Johnsson, H; Vesterqvist, O | 1 |
Bleifeld, W; Hamm, CW; Kupper, W; Lorenz, RL; Weber, PC; Wober, W | 1 |
Bernutz, C; Fischer, S; Meier, H; Weber, PC | 1 |
FitzGerald, GA; Reilly, IA | 1 |
Bode-Böger, SM; Böger, RH; Frölich, JC; Schröder, EP; Tsikas, D | 1 |
Gréen, K; Henriksson, P; Rasmanis, G; Vesterqvist, O | 1 |
Bulbena, O; Closa, D; Fernandez-Cruz, L; Gelpi, E; Hotter, G; Martrat, A; Rosello-Catafau, J | 1 |
Ilmonen, S; Rauramo, I; Viinikka, L; Ylikorkala, O | 1 |
Ibe, BO; Kurantsin-Mills, J; Lessin, LS; Natta, CL; Raj, JU; Siegel, RS | 1 |
Schweer, H; Seyberth, HW; Watzer, B | 1 |
Adatia, I; Barrow, SE; Haworth, SG; Miall-Allen, VM; Ritter, JM; Stratton, PD | 1 |
Blair, IA; Dougherty, RM; Iacono, JM; Phillips, MA; Prakash, C | 1 |
Adatia, I; Barrow, SE; Haworth, SG; Ritter, JM; Stratton, P | 1 |
Jendryczko, A; Tomala, J | 1 |
Helmerhorst, FM; Keirse, MJ; van der Weiden, RM | 1 |
Arosio, E; Lechi, A; Minuz, P; Pancera, P; Pirante, F; Ribul, M | 1 |
Gréen, K; Kimblad, PO; Sjöberg, T; Steen, S | 1 |
Dechaux, E; Dowell, FJ; Henrion, D; Lévy, BI; Maclour, J; Michel, JB; Samuel, JL | 1 |
Farker, K; Hoffmann, A; Nagel, U; Nassr, N; Oettel, M; Schweer, H; Seyberth, HW; Vollandt, R | 1 |
Arial, N; C-Gaudreault, R; De Grandpré, P; Forest, JC; Lindsay, C; Massé, J; Moutquin, JM | 1 |
Bernhard, M; Hoch, B | 1 |
Benthin, G; Hillbom, M; Kaste, M; Numminen, H; Syrjälä, M | 1 |
Böhme, M; Frölich, JC; Fuchs, I; Gutzki, FM; Tsikas, D | 1 |
Delemarre, FM; Jongsma, HW; Steegers, EA; Thomas, CM; van den Berg, RJ | 1 |
FitzGerald, GA; Li, H; Praticò, D; Tillmann, C; Zhang, ZB | 1 |
Kaaja, R; Leinonen, P; Pettilä, V; Ylikorkala, O | 1 |
Frölich, JC; Gutzki, FM; Kreutzer, FJ; Nowak, V; Stichtenoth, DO; Tsikas, D | 1 |
Pollock, DM; Pollock, JS; Sasser, JM; Sullivan, JC | 1 |
Hillbom, M; Juvela, S; Pyhtinen, J; Riutta, A; Saloheimo, P | 1 |
Filippou, DK; Stergioulas, AT | 1 |
Cheng, Y; Cyrus, T; Ding, T; Falotico, R; Ma, M; Praticò, D; Tian, H; Zhao, L | 1 |
12 trial(s) available for 2,3-dinor-thromboxane b2 and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Urinary excretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Chromatography, High Pressure Liquid; Climacteric; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Progestins; Radioimmunoassay; Thromboxane A2; Thromboxane B2 | 1990 |
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Allergens; Aspirin; Blood Platelets; Bronchial Spasm; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Female; Forced Expiratory Volume; Gas Chromatography-Mass Spectrometry; Humans; Male; Placebos; Platelet Activation; Thromboxane A2; Thromboxane B2 | 1989 |
Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Humans; Infusions, Intravenous; Injections; Male; Prostaglandins; Thromboxane B2; Thromboxanes | 1989 |
Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arteriosclerosis; beta-Thromboglobulin; Epoprostenol; Female; Humans; Imidazoles; Male; Middle Aged; Platelet Aggregation; Platelet Factor 4; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1986 |
Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Dinoprostone; Epoprostenol; Exercise; Gas Chromatography-Mass Spectrometry; Humans; Male; Physical Endurance; Physical Fitness; Platelet Aggregation; Thromboxane B2 | 1995 |
Dietary modification of omega 6 fatty acid intake and its effect on urinary eicosanoid excretion.
Topics: 6-Ketoprostaglandin F1 alpha; Chromatography, Thin Layer; Dietary Fats; Dinoprostone; Eicosanoids; Energy Intake; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Humans; Linoleic Acid; Linoleic Acids; Middle Aged; Thromboxane B2 | 1993 |
Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients.
Topics: 6-Ketoprostaglandin F1 alpha; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cyclooxygenase Inhibitors; Epoprostenol; Heart Function Tests; Heart Rate; Humans; Hypertension; Ibuprofen; Lisinopril; Male; Middle Aged; Prostaglandins; Thromboxane A2; Thromboxane B2; Vasodilator Agents | 1996 |
The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Adult; Alcoholic Intoxication; Biomarkers; Circadian Rhythm; Creatinine; Cross-Over Studies; Disease Susceptibility; Drug Administration Schedule; Ethanol; Fibrinolysis; Hemorheology; Hemostasis; Humans; Male; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Platelet Activation; Platelet Aggregation; Stroke; Supine Position; Thromboxane B2 | 2000 |
Urinary prostaglandin excretion in pregnancy: the effect of dietary sodium restriction.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Creatinine; Diet, Sodium-Restricted; Epoprostenol; Female; Humans; Hypertension; Longitudinal Studies; Postpartum Period; Pregnancy; Prostaglandins; Random Allocation; Sodium; Thromboxane A2; Thromboxane B2; Water-Electrolyte Balance | 2000 |
Increased thromboxane production in women with a history of venous thromboembolic event: effect of heparins.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Anticoagulants; Body Mass Index; Case-Control Studies; Dalteparin; Factor V; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Statistics, Nonparametric; Thromboxane B2; Thromboxanes; Venous Thrombosis | 2001 |
Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arterial Occlusive Diseases; Dinoprost; Epoprostenol; F2-Isoprostanes; Female; Gas Chromatography-Mass Spectrometry; Humans; Infusions, Intravenous; Kinetics; Male; Middle Aged; Nitrates; Oxygen; Thromboxane B2 | 2001 |
Effects of physical conditioning on lipids and arachidonic acid metabolites in untrained boys: a longitudinal study.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Arachidonic Acid; Body Weight; Child; Cholesterol; Cholesterol, HDL; Heart Rate; Humans; Lipids; Longitudinal Studies; Male; Physical Endurance; Physical Exertion; Physical Fitness; Thromboxane B2; Triglycerides | 2006 |
68 other study(ies) available for 2,3-dinor-thromboxane b2 and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Age Factors; Cardiovascular Diseases; Female; Gas Chromatography-Mass Spectrometry; Humans; Middle Aged; Platelet Activation; Risk Factors; Smoking; Smoking Cessation; Thromboxane B2 | 1992 |
Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children.
Topics: 6-Ketoprostaglandin F1 alpha; Age Factors; Child; Child, Preschool; Circadian Rhythm; Dinoprost; Dinoprostone; Humans; Infant; Infant, Newborn; Reference Values; Thromboxane B2 | 1992 |
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Radioimmunoassay; Thromboxane A2; Thromboxane B2 | 1992 |
Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Biomarkers; Blood Platelets; Blood Vessels; Female; Humans; Menstruation; Middle Aged; Platelet Activation; Smoking; Thromboxane B2 | 1991 |
Thromboxane dominance and prostacyclin deficiency in habitual abortion.
Topics: 6-Ketoprostaglandin F1 alpha; Abortion, Habitual; Epoprostenol; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Thromboxane A2; Thromboxane B2 | 1991 |
Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Female; Humans; Indomethacin; Kinetics; Nylidrin; Obstetric Labor, Premature; Pregnancy; Thromboxane B2; Tocolysis | 1992 |
Arachidonic acid does not share the antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids in a model of angiotensin II-induced hypertension in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acid; Fatty Acids, Omega-3; Hypertension; Indomethacin; Linoleic Acid; Linoleic Acids; Male; Rats; Rats, Inbred Strains; Thromboxane B2 | 1991 |
Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Biomarkers, Tumor; Choriocarcinoma; Epoprostenol; Female; Humans; Pregnancy; Reference Values; Thromboxane A2; Thromboxane B2; Uterine Neoplasms | 1991 |
Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Creatinine; Cyclooxygenase Inhibitors; Epoprostenol; Ibuprofen; In Vitro Techniques; Interleukin-1; Kidney Glomerulus; Male; Nephritis; Neutrophils; Rats; Rats, Inbred Strains; Thromboxane B2; Thromboxanes | 1991 |
Prostacyclin production in myocardial infarction in the acute phase and during follow-up.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Creatine Kinase; Epoprostenol; Exercise Test; Female; Follow-Up Studies; Humans; Isoenzymes; Male; Middle Aged; Monitoring, Physiologic; Myocardial Infarction; Thromboxane A2; Thromboxane B2 | 1991 |
Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Epoprostenol; Humans; Male; Osmolar Concentration; Smoking; Thromboxane A2; Thromboxane B2 | 1991 |
Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
Topics: 6-Ketoprostaglandin F1 alpha; Dinoprost; Dinoprostone; Gas Chromatography-Mass Spectrometry; Humans; Indicators and Reagents; Prostaglandin D2; Prostaglandins; Thromboxane B2 | 1991 |
Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Humans; Imidazoles; Male; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1990 |
Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aging; Blood Platelets; Cardiovascular Physiological Phenomena; Fathers; Humans; Infections; Male; Physical Fitness; Thromboxane B2 | 1990 |
Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Female; Humans; Male; Naproxen; Thromboxane A2; Thromboxane B2 | 1989 |
Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Chromatography, Affinity; Gas Chromatography-Mass Spectrometry; Humans; Male; Rats; Rats, Inbred Strains; Thromboxane B2 | 1989 |
An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cyclosporins; Epoprostenol; Female; Humans; Hypertension; Male; Multiple Sclerosis; Thromboxane A2; Thromboxane B2 | 1989 |
Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol).
Topics: 6-Ketoprostaglandin F1 alpha; Acetaminophen; Adult; Depression, Chemical; Epoprostenol; Humans; Thromboxane B2; Time Factors | 1989 |
Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Female; Humans; Male; Middle Aged; Platelet Count; Prospective Studies; Purpura, Thrombocytopenic; Thrombocytopenia; Thromboxane A2; Thromboxane B2 | 1989 |
Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Bacterial Infections; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Thromboxane A2; Thromboxane B2 | 1989 |
Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.
Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Endometriosis; Epirubicin; Female; Humans; Middle Aged; Ovarian Neoplasms; Thromboxane B2 | 1989 |
Myocardial ischaemia triggers formation of thromboxane.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Angina Pectoris; Humans; Male; Middle Aged; Physical Exertion; Thromboxane B2 | 1987 |
In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC-MS measurements of major urinary metabolites.
Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Blood Vessel Prosthesis; Epoprostenol; Gas Chromatography-Mass Spectrometry; Humans; Myocardial Infarction; Thromboxane A2; Thromboxane B2 | 1986 |
In vivo synthesis of thromboxane A2 and prostaglandin I2 in healthy and diseased individuals.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Disease; Epoprostenol; Humans; Reference Values; Thromboxane A2; Thromboxane B2 | 1987 |
Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans.
Topics: 6-Ketoprostaglandin F1 alpha; Arteriosclerosis; Blood Platelets; Epoprostenol; Humans; Leg; Physical Exertion; Thromboxane B2 | 1987 |
Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Female; Humans; Kidney; Male; Radioimmunoassay; Sulindac; Thromboxane B2 | 1987 |
Combined high-performance liquid chromatography and enzyme immunoassay for the determination of urinary metabolites of thromboxane and 6-keto-PGF1 alpha.
Topics: 6-Ketoprostaglandin F1 alpha; Chromatography, High Pressure Liquid; Fatty Acids, Unsaturated; Female; Humans; Immunoenzyme Techniques; Male; Thromboxane B2 | 1987 |
In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arteriosclerosis; beta-Thromboglobulin; Bleeding Time; Blood Platelets; Dietary Fats; Eicosapentaenoic Acid; Epoprostenol; Erythrocytes; Fatty Acids; Fish Oils; Humans; Male; Middle Aged; Phospholipids; Platelet Count; Platelet Factor 4; Thromboxane A2; Thromboxane B2; Thromboxanes | 1986 |
Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cold Temperature; Female; Humans; Male; Middle Aged; Raynaud Disease; Scleroderma, Systemic; Thromboxane A2; Thromboxane B2 | 1986 |
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aged, 80 and over; Aging; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Fatty Acids, Unsaturated; Humans; Hydroxyeicosatetraenoic Acids; Platelet Aggregation; Thromboxane B2; Vitamin E | 1988 |
Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arteriosclerosis; Carotid Artery Diseases; Cotinine; Diseases in Twins; Humans; Male; Middle Aged; Smoking; Thromboxane B2; Twins; Twins, Monozygotic; Ultrasonography | 1988 |
Excretion of primary prostanoids and their metabolites during acute volume expansion.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Blood Volume; Dinoprost; Dinoprostone; Diuresis; Female; Gas Chromatography-Mass Spectrometry; Glomerular Filtration Rate; Humans; Hydrogen-Ion Concentration; Kidney; Male; Osmolar Concentration; Prostaglandins; Prostaglandins E; Prostaglandins F; Thromboxane B2; Urine | 1988 |
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Disease; Coronary Thrombosis; Dibenzothiepins; Dogs; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Thromboxane B2; Thromboxane-A Synthase | 1988 |
Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
Topics: 6-Ketoprostaglandin F1 alpha; Acrylates; Adolescent; Adult; Aged; Female; Glomerulonephritis; Humans; Male; Methacrylates; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Proteinuria; Thromboxane B2; Thromboxane-A Synthase | 1988 |
Urinary metabolites of thromboxane and prostacyclin in diabetes mellitus.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Blood Glucose; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Thromboxane B2 | 1988 |
Thromboxane biosynthesis and platelet function in type I diabetes mellitus.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Blood Platelets; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Epoprostenol; Humans; Insulin; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1988 |
Synthetic arterial grafts cause prolonged increase in the in vivo formation of thromboxane and prostacyclin in humans.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aorta, Abdominal; Aortic Aneurysm; Blood Vessel Prosthesis; Cholecystectomy; Epoprostenol; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Postoperative Period; Smoking; Thromboxane A2; Thromboxane B2 | 1987 |
Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Alcoholism; Epoprostenol; Ethanol; Humans; Male; Middle Aged; Prostaglandins E; Prostanoic Acids; Substance Withdrawal Syndrome; Thromboxane B2; Thromboxanes | 1987 |
In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Female; Gas Chromatography-Mass Spectrometry; Hip Prosthesis; Humans; Male; Thrombosis; Thromboxane B2 | 1988 |
Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Female; Humans; Intermittent Claudication; Male; Middle Aged; Physical Exertion; Thromboxane B2 | 1988 |
Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Epoprostenol; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Prostaglandin Antagonists; Thromboxane B2; Time Factors | 1986 |
Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants.
Topics: 6-Ketoprostaglandin F1 alpha; Ductus Arteriosus, Patent; Epoprostenol; Gas Chromatography-Mass Spectrometry; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Prospective Studies; Thromboxane B2 | 1986 |
In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.
Topics: 6-Ketoprostaglandin F1 alpha; Epoprostenol; Humans; Infusions, Parenteral; Myocardial Infarction; Thromboxane B2; Thromboxanes | 1986 |
Platelet activation in unstable coronary disease.
Topics: 6-Ketoprostaglandin F1 alpha; Angina Pectoris; Angina, Unstable; Blood Platelets; Epoprostenol; Humans; Myocardial Infarction; Thromboxane A2; Thromboxane B2 | 1986 |
Effects of sulindac on renal and extrarenal eicosanoid synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Adult; Epoprostenol; Female; Humans; Indenes; Kidney; Male; Radioimmunoassay; Sulindac; Thromboxane A2; Thromboxane B2 | 1987 |
Thromboxane and prostacyclin formation in patients with deep vein thrombosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Blood Platelets; Epoprostenol; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Thrombophlebitis; Thromboxane A2; Thromboxane B2; Thromboxanes; Time Factors | 1987 |
Biochemical evidence of platelet activation in patients with persistent unstable angina.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Angina Pectoris; Angina, Unstable; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Monitoring, Physiologic; Platelet Aggregation; Thromboxane B2 | 1987 |
Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aging; Child, Preschool; Creatinine; Gas Chromatography-Mass Spectrometry; Humans; Infant, Newborn; Kinetics; Thromboxane B2 | 1986 |
Eicosenoid biosynthesis and platelet function with advancing age.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aging; Bleeding Time; Blood Platelets; Creatinine; Eicosanoic Acids; Female; Humans; Male; Middle Aged; Platelet Aggregation; Reference Values; Thromboxane B2 | 1986 |
Implications of the prognostic importance of exercise-induced thromboxane formation in survivors of an acute myocardial infarction.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic beta-Antagonists; Adult; Aged; Aspirin; Epoprostenol; Exercise; Exercise Test; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Thromboxane A2; Thromboxane B2 | 1995 |
Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Amylases; Animals; Ceruletide; Epoprostenol; Gabexate; Lipase; Male; Pancreatitis; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Thromboxane A2; Thromboxane B2 | 1993 |
Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Exercise; Female; Humans; Pregnancy; Thromboxane B2 | 1995 |
Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Anemia, Sickle Cell; Blood Platelets; Dinoprostone; Endothelium, Vascular; Humans; Middle Aged; Thromboxane B2 | 1994 |
Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry.
Topics: 6-Ketoprostaglandin F1 alpha; Chromatography, Thin Layer; Dinoprostone; Gas Chromatography-Mass Spectrometry; Humans; Prostaglandins; Thromboxane B2 | 1994 |
Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aging; Cardiac Surgical Procedures; Child; Child, Preschool; Epoprostenol; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Infant; Male; Postoperative Period; Pulmonary Heart Disease; Reference Values; Thromboxane A2; Thromboxane B2 | 1993 |
Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Child, Preschool; Epoprostenol; Female; Heart Defects, Congenital; Humans; Infant; Male; Thromboxane A2; Thromboxane B2; Ventricular Outflow Obstruction | 1993 |
An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause.
Topics: 6-Ketoprostaglandin F1 alpha; Epoprostenol; Female; Humans; Menopause; Middle Aged; Poland; Reference Values; Thromboxane A2; Thromboxane B2 | 1993 |
Prostanoid excretion before in vitro fertilization relates to the likelihood of pregnancy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Chromatography, High Pressure Liquid; Embryo Transfer; Epoprostenol; Female; Fertilization in Vitro; Humans; Pregnancy; Pregnancy Outcome; Thromboxane A2; Thromboxane B2 | 1995 |
Prostanoid release after lung transplantation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Gas Chromatography-Mass Spectrometry; Lung Transplantation; Pulmonary Artery; Swine; Thromboxane A2; Thromboxane B2; Time Factors; Vascular Resistance | 1996 |
Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase 1; Cyclooxygenase 2; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Isoenzymes; Isoquinolines; Male; Membrane Proteins; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; Prostaglandin-Endoperoxide Synthases; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Thromboxane B2; Vascular Resistance; Vasodilation | 1997 |
Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Dinoprostone; Female; Follicular Phase; Humans; Luteal Phase; Menstrual Cycle; Middle Aged; Ovulation; Postmenopause; Prostaglandins; Thromboxane B2 | 1997 |
Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study.
Topics: 6-Ketoprostaglandin F1 alpha; Chronic Disease; Creatinine; Epoprostenol; Female; Humans; Hypertension; Kidney; Longitudinal Studies; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prospective Studies; Reference Values; Thromboxane B2 | 1997 |
Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants.
Topics: 6-Ketoprostaglandin F1 alpha; Apnea; Birth Weight; Epoprostenol; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Polysomnography; Prostaglandins F; Thromboxane A2; Thromboxane B2 | 1999 |
Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine.
Topics: 6-Ketoprostaglandin F1 alpha; Chromatography, Thin Layer; Gas Chromatography-Mass Spectrometry; Humans; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Thromboxane B2 | 2000 |
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Artery Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epoprostenol; Female; Indomethacin; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Receptors, LDL; Sulfonamides; Thromboxane B2 | 2001 |
Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blotting, Western; Castration; Cyclooxygenase 2; Female; Intramolecular Oxidoreductases; Kidney; Kidney Medulla; Male; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Inbred SHR; Sex Characteristics; Thromboxane B2; Tissue Distribution | 2005 |
Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Aged; Aspirin; Bleeding Time; Blood Coagulation; Cerebral Hemorrhage; Epoprostenol; Female; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Thromboxane A2; Thromboxane B2 | 2005 |
Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Atherosclerosis; Cholesterol; Collagen; Creatinine; Cytokines; Diet, Atherogenic; Dose-Response Relationship, Drug; Inflammation; Isoprostanes; Male; Mice; Mice, Knockout; Random Allocation; Receptors, LDL; Sirolimus; Thromboxane B2; Time Factors; Triglycerides | 2009 |